Kenvue (MEX:KVUE) Net Income From Continuing Operations : MXN21,302 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Kenvue Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Kenvue's net income from continuing operations for the three months ended in Mar. 2025 was MXN6,588 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was MXN21,302 Mil.

Kenvue Net Income From Continuing Operations Historical Data

The historical data trend for Kenvue's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kenvue Net Income From Continuing Operations Chart

Kenvue Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

-17,485.07

42,628.09

40,239.74

28,245.15

21,481.37

Kenvue Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial										4,912.49	1,062.57	7,541.39	6,110.72	6,587.54

Kenvue Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN21,302 Mil.

Kenvue Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (MEX:KVUE) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

KVUE:USA J4D:Germany

Address

199 Grandview Road, Skillman, NJ, USA, 08558

Website

https://www.kenvue.com

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.